2 completed, 1 not yet recruiting, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Helicobacter: new trials by email Literature Review of Helicobacter trials Research Report on Helicobacter
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori 7-day high-dose vonoprazan-amoxicillin dual therapy group, 14-day vonoprazan-amoxicillin dual therapy group - Helicobacter | Not applicable | Not yet recruiting | Yueyue Li | 290 | 2026-02-01 | 2026-01-20 |
| Efficacy of Probiotics in the Gut Microbiota and H Pylori Density Probiotic, Placebo - Helicobacter | Phase 2 / Phase 3 | Completed | Statistical Center, NTUHCTC | 40 | 2016-03-01 | 2021-06-29 |
| Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication 14-day sequential therapy, Bismuth quadruple therapy - Helicobacter | Phase 4 | Unknown | National Taiwan University Hospital | 620 | 2015-09-01 | 2017-05-17 |
| Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP Levofloxacin based sequential therapy, bismuth quadruple therapy for 10 days (BQ) - Helicobacter | Phase 3 | Completed | National Taiwan University Hospital | 560 | 2015-02-01 | 2022-06-08 |
Probiotics (1) · Tuberculin (1) · ribosomal protein S14 (1)
National Taiwan University Hospital (2) · Statistical Center, NTUHCTC (1) · Yueyue Li (1)
Taiwan (3) · China (1)
Jyh-Ming Liou (1) · Jyh-Ming Liou, MD, PhD (1) · Ming-Shiang Wu (1) · Ming-Shiang Wu, MD, PhD (1)
PMID 21632579, PMID 23099849, PMID 23158886, PMID 29846605, PMID 34708471, PMID 36549320